Masitinib in Combination With Gemcitabine in Advanced/Metastatic Epithelial Ovarian Cancer Patients
Clinical trial NCT02490488 · COMPLETED
Trial details
- NCT number
- NCT02490488
- Sponsor
- AB Science
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2020-12-01
- Enrollment
- 248
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.